Literature DB >> 8818350

Rat pineal alpha 1-adrenoceptor subtypes: studies using radioligand binding and reverse transcription-polymerase chain reaction analysis.

D Sugden1, N Anwar, D C Klein.   

Abstract

1. The pharmacological characteristics of alpha 1-adrenoceptor binding sites in rat pineal gland membranes, detected by use of a selective alpha 1-adrenoceptor antagonist ([125I]-iodo-2-[beta-(4-hydroxyphenyl) ethylaminomethyl]tetralone, [125I]-HEAT), were investigated with the alkylating agent, chloroethylclonidine (CEC), and in competition experiments with a number of adrenoceptor agonists and antagonists. 2. Chloroethylclonidine (CEC) treatment (10 microM, 10 min) of rat pineal membranes inactivated approximately 70% of specific [125I]-HEAT binding sites. Higher concentrations of CEC (up to 100 microM) or longer treatment periods (up to 40 min) were no more effective. 3. Adrenoceptor agonists and antagonists competitively inhibited [125I]-HEAT binding with Hill coefficients close to unity indicating a single alpha 1-adrenoceptor subtype is present. The affinity (Ki) of subtype selective agonists (oxymetazoline, SDZ NVI-085) and antagonists (5-methylurapidil, WB4101, benoxathian, phentolamine) was consistent with binding to an alpha 1B-adrenoceptor subtype. 4. The (-)- and (+)-enantiomers of niguldipine had an equal and low affinity for alpha 1-adrenoceptor binding sites both in untreated (log Ki-6.66 and -6.90 respectively) and CEC-treated membranes in which approximately 70% of sites had been inactivated (log Ki-6.41 and -6.86 respectively). This indicates that the small proportion of alpha 1-adrenoceptors insensitive to CEC are not alpha 1A-adrenoceptors. 5. mRNA was isolated from rat pinealocytes, cDNA was synthesized and then amplified by the polymerase chain reaction with alpha 1-adrenoceptor subtype specific primers. These experiments identified both alpha 1A- and alpha 1B-adrenoceptor mRNA, but not alpha 1D-mRNA in rat pinealocytes, although all three adrenoceptor subtypes were readily identified in rat brain cortex. 6. These data indicate that although both alpha 1A- and alpha 1B-adrenoceptor mRNAs are present in the pineal the major subtype of alpha 1-adrenoceptor expressed is the alpha 1B.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818350      PMCID: PMC1909588          DOI: 10.1111/j.1476-5381.1996.tb15530.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Activation of protein kinase C potentiates isoprenaline-induced cyclic AMP accumulation in rat pinealocytes.

Authors:  D Sugden; J Vanecek; D C Klein; T P Thomas; W B Anderson
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

Review 2.  International Union of Pharmacology nomenclature of adrenoceptors.

Authors:  D B Bylund; D C Eikenberg; J P Hieble; S Z Langer; R J Lefkowitz; K P Minneman; P B Molinoff; R R Ruffolo; U Trendelenburg
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

3.  Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype.

Authors:  D M Perez; M T Piascik; N Malik; R Gaivin; R M Graham
Journal:  Mol Pharmacol       Date:  1994-11       Impact factor: 4.436

4.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  Atypical synergistic alpha 1- and beta-adrenergic regulation of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in rat pinealocytes.

Authors:  J Vanecek; D Sugden; J Weller; D C Klein
Journal:  Endocrinology       Date:  1985-06       Impact factor: 4.736

7.  Development of the rat pineal alpha 1-adrenoceptor.

Authors:  D Sugden; D C Klein
Journal:  Brain Res       Date:  1985-01-28       Impact factor: 3.252

8.  Essential role of calcium influx in the adrenergic regulation of cAMP and cGMP in rat pinealocytes.

Authors:  A L Sugden; D Sugden; D C Klein
Journal:  J Biol Chem       Date:  1986-09-05       Impact factor: 5.157

9.  Rat pineal alpha 1-adrenoceptors: identification and characterization using [125I]iodo-2-[beta-(4-hydroxyphenyl)-ethylaminomethyl]tetralone.

Authors:  D Sugden; D C Klein
Journal:  Endocrinology       Date:  1984-02       Impact factor: 4.736

10.  Regulation of rat pineal alpha 1-adrenoceptors.

Authors:  D Sugden; D C Klein
Journal:  J Neurochem       Date:  1985-01       Impact factor: 5.372

View more
  3 in total

1.  Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery.

Authors:  W B Stam; P H Van der Graaf; P R Saxena
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Night/day changes in pineal expression of >600 genes: central role of adrenergic/cAMP signaling.

Authors:  Michael J Bailey; Steven L Coon; David A Carter; Ann Humphries; Jong-So Kim; Qiong Shi; Pascaline Gaildrat; Fabrice Morin; Surajit Ganguly; John B Hogenesch; Joan L Weller; Martin F Rath; Morten Møller; Ruben Baler; David Sugden; Zoila G Rangel; Peter J Munson; David C Klein
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

3.  Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.

Authors:  David L Wirta; Michael S Korenfeld; Shane Foster; Robert Smyth-Medina; Jason Bacharach; Shane R Kannarr; Mark J Jaros; Charles B Slonim
Journal:  Clin Ophthalmol       Date:  2021-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.